Ingestible Sensors Market (2026 - 2033)

Ingestible Sensors Market Summary

The global ingestible sensors market size was valued at USD 1.4 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 5.3 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 40.0% in 2025. An ingestible sensor is a vital healthcare device that aids in diagnosis and monitoring.

Technological advancements and the growing prevalence of chronic diseases are among the major factors driving the market. Factors, including the need for medical adherence and increasing healthcare awareness among people, are likely to boost the market growth. Extensive product use across various medical applications, including modified drug delivery, is contributing to market growth. These devices are non-invasive and feature a user-friendly design that supports real-time diagnosis and health monitoring. Increasing cases of complications caused by various chronic diseases, resulting from patients' negligence in following prescriptions, are boosting product demand.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The adoption of the Internet of Things in the medical/healthcare industry is on the rise. This has resulted in increased research on smart pills and Wireless Observed Therapy (WOT). In June 2025, Atmo Biosciences received U.S. FDA 510(k) clearance for its Atmo Gas Capsule System, an ingestible gas-sensing capsule designed to measure gastrointestinal gases and provide real-time diagnostic insights into gut motility disorders. The system combines an ingestible sensor capsule with digital analytics, highlighting the growing integration of connected healthcare technologies and ingestible sensing platforms.

Stringent government regulations and the need for expensive technology are among the factors that could hinder this market's growth. Product design and development is an expensive process and requires advanced integrated technologies and high-end R&D infrastructure. Moreover, regulatory authorities set strict guidelines to ensure the safety and effectiveness of a proposed medical product.

According to the International Diabetes Federation (IDF), approximately 589 million adults worldwide were living with diabetes in 2025, highlighting the growing burden of chronic diseases and the increasing need for advanced monitoring and disease management technologies, including ingestible sensor-based solutions. This rising prevalence of chronic diseases is increasing the need for medical products to control and manage various chronic diseases. Smart pills can be useful in the management of such diseases, as they are non-invasive, wireless, and can reduce the burden on care providers.

According to the International Diabetes Federation (IDF), nearly 537 million adults were living with diabetes in the world in 2021. The number is projected to reach 643 million by 2030. Nearly 11.0% of Americans have a chronic digestive disease. This rising prevalence of chronic diseases is increasing need for the medical products to control and manage various chronic diseases. Smart pills can prove to be useful in the management of such diseases as they are non-invasive, wireless, and can reduce the burden on care providers.

Market Dynamics

The ingestible sensors market is witnessing steady growth, driven by increasing demand for advanced diagnostic and patient-monitoring technologies that enable real-time health assessment and treatment management. Growing awareness of the benefits of non-invasive monitoring, the rising prevalence of chronic diseases, and the increasing adoption of connected healthcare solutions are driving the use of ingestible sensors across diagnostic, medication adherence, and disease management applications. In addition, the growing popularity of digital health platforms and remote patient monitoring systems, along with innovation in miniaturized sensor technologies and wireless communication capabilities, is further supporting market expansion.

Analyst Perspective

The ingestible sensors market is witnessing steady growth, driven by rising adoption of digital health technologies and increasing prevalence of chronic diseases. Growing demand for remote patient monitoring, medication adherence, and real-time health tracking is supporting market expansion. The integration of IoT-enabled medical devices and connected healthcare platforms is further accelerating adoption. Companies focusing on product innovation, advanced technologies, and diverse healthcare applications are expected to gain a competitive advantage.

Components Insights

By component, the sensor segment dominated the market in 2025 with a share of over 45.0%, and it is projected to register the highest CAGR over the forecast period, attributed to huge R&D investments and new product launches. For instance, in April 2025, Celero Systems advanced the development of its ingestible biosensing platform, designed to continuously monitor biomarkers in the gastrointestinal tract, highlighting the growing innovation in miniaturized sensor technologies for medical applications. The sensor technology also helps reduce hospital visits and rehospitalizations, along with round-the-clock remote monitoring, thereby allowing patients to recover in the comfort of their own homes.

The software segment is expected to grow robustly over the forecast period. The segment's growth is mainly driven by manufacturers' ongoing efforts to introduce advanced software that offers more effective ways to control and manage disease. The increasing adoption of wearable patches for disease monitoring among the patient population is likely to favor growth in the wearable patch/data recorder segment. As per the Canadian Diabetes Association, the prevalence of the disease is growing in Canada, and it is said to affect around 5.0 million individuals in 2025. Thus, increasing incidences of chronic diseases such as diabetes, cancer, arthritis, Alzheimer’s disease, chronic kidney disease, and chronic pain are expected to boost the segment growth.

Vertical Insights

Based on the vertical, the medical segment, with a share of over 55.0%, accounted for the largest share of the market in 2025 and is expected to have the fastest CAGR during the forecast period. These products are widely used in the medical sector, where they help diagnose diseases and monitor patient health. In contrast to invasive techniques, which require meticulous procedures and surgical interventions, ingestible sensors enable simplified monitoring of parameters such as temperature, pressure, and pH.

The sports segment is expected to witness lucrative growth during the forecast period. Constant monitoring of blood pressure, melatonin levels, and other essential body statistics is required to assess the health of players and athletes. They also help athletes monitor food interactions and record relevant data accurately without invasive techniques. All these factors are boosting the product demand in this field.

Edible sensors are used in other areas where the study of internal anatomy is required. Individuals working in extreme conditions, such as firefighters and defense personnel, are also required to continuously monitor body temperature and other essential parameters, which is augmenting the segment's growth.

Sensor Type Insights

The temperature sensor held the largest revenue share of over 35.0% in 2025. It is a widely used technique across verticals such as healthcare and aerospace to measure body temperature in patients and astronauts, respectively, to detect any drastic temperature changes that might prove fatal if undetected.

The investments in the product’s R&D are higher in developed countries than in emerging regions because of the high cost of the technology, the availability of well-equipped labs, and early adoption of advanced medical products in developed regions.

The image sensor segment is projected to grow at the fastest CAGR during the forecast period, driven by its growing adoption in the healthcare sector. They are widely used in endoscopy procedures. Healthcare professionals can view clear images of various tissues and organs inside a patient’s body by using these sensors, which allows for accurate diagnosis of critical diseases.

Regional Insights

North America accounted for the largest share of more than 40.0% in the global ingestible sensors market in 2025, owing to technological advancements and the strategic presence of key manufacturers. Innovations in science and technology that led to the development of tiny camera pills, widely used in these products, are likely to boost the region’s growth. Furthermore, increasing research into the use of smart pills for the management of chronic and gastrointestinal diseases is favoring market expansion.

To learn more about this report, Download Free Sample Report

Asia Pacific Ingestible Sensors Market Trends

Asia Pacific is anticipated to witness the fastest CAGR over the forecast period, driven by rising healthcare expenditure and the prevalence of chronic diseases. Heavy investments by the top companies in R&D are also likely to contribute to regional growth. Countries such as Japan, India, and China are expected to lead the region with increasing adoption of these medical devices for diagnostics and therapeutic purposes. Increased cases of lifestyle-related diseases, driven by physical inactivity and unhealthy eating habits, are also likely to boost product demand in the region.

Key Ingestible Sensors Company Insights

The major players are focusing on robust R&D, new product launches, and partnerships for strengthening their market positions. Competition in the global ingestible sensors market is expected to be intense, driven by numerous players. In response to changing consumer trends, several companies are expanding their product ranges to gain a competitive advantage.

Key Ingestible Sensors Companies

The following key companies have been profiled for this study on the ingestible sensors market.

• Olympus Corporation

• Otsuka Holdings Co., Ltd.

• Medtronic

• etectRx

• CapsoVision, Inc.

• H.Q., Inc.

• IntroMedic

• JINSHAN Science & Technology

• Check-Cap

Recent Developments

• In May 2025, AnX Robotica unveiled the NaviCam XS capsule endoscopy system and ESView 3.0 platform at DDW 2025, expanding its ingestible diagnostic technology portfolio with a capsule that is 44% smaller than conventional small bowel capsules. The launch highlights ongoing advancements in minimally invasive gastrointestinal diagnostics and capsule endoscopy technologies.

• In May 2025, imec introduced a highly miniaturized ingestible sensor prototype for gut health monitoring capable of measuring redox balance within the gastrointestinal tract. The innovation provides valuable insights into intestinal inflammation and microbiome health, reflecting the growing focus on precision diagnostics and next-generation ingestible medical devices. 

Global Ingestible Sensors Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ingestible sensors market report based on the component, sensor type, vertical, and region:

To learn more about this report, Download Free Sample Report

• Component Outlook (Revenue, USD Billion, 2021 - 2033)

  • Sensor

  • Wearable Patch/Data Recorder

  • Software

• Sensor Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Temperature Sensor

  • Pressure Sensor

  • pH Sensor

  • Image Sensor

• Vertical Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical

  • Sports And Fitness

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Mexico

    • Brazil

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE